Hidradenitis Suppurativa

Hidradenitis suppurativa is a chronic, pus-producing (suppurative), scarring (cicatricial) disease process that occurs due to obstruction of hair follicles and secondary infection and inflammation of certain sweat glands (apocrine glands), particularly those under the arms (axillae) or within the anal/genital (anogenital) region. The disease is characterized by the development of recurrent, boil-like nodular lesions and deep pus-containing pockets of infection (abscesses) that may eventually rupture through the skin. Healing of affected areas is typically associated with progressive scarring (fibrosis). The specific underlying cause of hidradenitis suppurativa is unknown. This is a relapsing condition occurring, most commonly in women. It is an androgen-dependent disorder and results from keratinous material occluding the sweat pores. There is an association with lithium therapy and Crohn's disease.

Etiology

HS often occurs in multiple members within families, suggesting a genetic predisposition. Various etiological agents have been associated. The increased incidence of HS in obese women with acne led to the theory of HS being associated with an hyperandrogenic endocrine disorder. One study did not find evidence for biochemical hyperandrogenism in women affected with HS. Thus, the role of androgens in HS is still not clear. Smoking, lithium and oral contraceptives may also be associated with HS, possibly as triggering factors. Nonetheless, the etiology of the disease is unknown. 

Hidradenitis SuppurativaFrequency

In the US : In the United States , the prevalence of HS appears to be 1-2% in the general population. 

Internationally : The prevalence of HS appears to be 1% of the general population; it was 4% in a group of young adults who were treated at a clinic for sexually transmitted diseases. HS is probably more common than once thought, but the diagnosis is frequently ignored or missed. HS has a worldwide distribution, though hot, humid environments tend to support its development. 

Pathogenesis of Hidradenitis Suppurativa

Historically, apocrinitis was believed to be the defining histologic feature and pathogenetic mechanism of HS. Characteristic lobular abscesses in the apocrine gland, demonstrated histologically, seemed to further implicate apocrine gland involvement in the manifestation of disease. Recently, histological evidence points to HS being a follicular disease. Histological examination in the majority of specimens reveals follicular involvement, including poral occlusion and folliculitis. Apocrinitis as the dominant histological feature is found in only a small number of specimens. Furthermore, a paucity of apocrine glands was demonstrated in the genitofemoral region, one area commonly affected by HS. This finding supports the theory that apocrine gland inflammation is not the etiological and pathogenetic mechanism of HS, but rather a secondary manifestation of follicular involvement. 

Hidradenitis SuppurativaMortality/Morbidity

The death rate is similar to that in the general adult population. 

Although rare complications of the disease are described, little is known about the typical effects of HS. HS is a chronic disabling disorder that relentlessly progresses and leads to keloids, contractures, and immobility; patients can become outcasts or at least have difficulty in making social contact. 

Therapy for Hidradenitis Suppurativa

Treatment of hidradenitis suppurativa is challenging. Late stage disease, evidenced by the formation of sinus tracts, fibrosis and scarring, usually necessitates surgical intervention. Early HS is sometimes treated with antibiotics in our experience, although few clinical trials are available.

Medical therapy is of limited value once HS has progressed past its early stage. The surgical option of choice for late stage HS is wide local excision with healing by secondary intention. One study examined patients with chronic HS who had undergone surgery between the years of 1976 and 1997. An estimated 72-month follow-up revealed that 45% of the patients had recurrence of local HP. A 100% recurrence rate was reported after drainage procedures, while limited and wide local excision techniques had a recurrence rate of 42.8% and 27%, respectively. More recently, carbon dioxide laser excision has been proposed as a better alternative to conventional surgery. Carbon dioxide laser excision offers better hemostasis and visualization of abscessed tissue than conventional surgical techniques, allowing more accurate excision. 

Clinical Features of Hidradenitis Suppurativa

HS may arise singularly or multifocally in the genitofemoral, perianal and axillary areas. The lesions are painful and have a foul odor attributed to bacterial colonization. Erythematous dermal abscesses form that measure up to 2 cm in diameter. Untreated abscesses will gradually increase in size and may drain to the surface. The course of HS is chronic and remitting, with new abscesses arising in previously unaffected areas or in regions of past involvement. Scarring, fibrosis and sinus tract formations are manifestations of late disease. Strictures can occur secondary to sinus tracts; fistulas may also complicate HS. Squamous cell carcinoma is a rare sequella of longstanding HS. These cancers may be locally aggressive with distant metastases and a high mortality rate.

Race/Sex/Age

Race: Although many authors report no racial predilection, an increased incidence is observed in blacks, possibly because blacks have a greater density of apocrine glands compared with whites. 

Sex: Although HS is widely considered to occur more frequently in females than in males, with a ratio as high as 2-5:1, reports on sex prevalence are controversial. Axillary involvement is probably more common in women than in men, whereas perianal and anogenital involvement tends to be more common in men. 

Advanced Colloidal Silver and the other supplements we sell are not drugs and the information and opinions we offer are based upon use of these products as Dietary Supplements only. We have no doctors on staff and do not offer medical advice concerning colloidal silver, colloidal gold or any other dietary supplements. Although you may choose to supplement with colloidal silver, colloidal gold, and other mineral and vitamin supplements, we suggest that you consult a licensed physician if you believe you have a life threatening health issue. We also recommend that you do comprehensive research about colloidal silver, colloidal gold and all dietary supplements in general before accepting our opinions or the opinions of anyone else about how to care for your health.

The USFDA has not evaluated, nor rendered approval for any statements or research cited herein, nor have they approved any representations or opinions concerning colloidal silver, colloidal gold or any other dietary supplement products on this website. These products are dietary supplements and are not intended to diagnose, cure, prevent or treat any disease.

Utopia Silver Supplements does not assume the role of representative, fiduciary or surety on behalf of any person(s) or individual(s) unless expressly agreed in writing. Anyone purchasing our supplements are believed by us to be responsible adults who have exercised their right to do research and are making an informed decision. All rights are reserved, without prejudice.